Social Determinants
|
Demographic
|
Dependency Ratio
|
Population total dependency ratio |
2000-2011 |
World Bank |
Socio-economic
|
Income
|
% population below poverty line |
2004-2010 |
World Bank |
GDP per capita (dollars at current prices) |
2000-2013 |
WolrdBank – OECD. |
Work
|
% of informality |
2000-2012 |
CEPAL |
Unemployment rate |
2000-2013 |
CEPAL |
Inequality
|
GINI Index |
2000-2010 |
World Bank |
Education
|
PISA: mathematical performance |
2000, 2003, 2006, 2009 |
PISA-OECD |
PISA: reading performance |
2000, 2003, 2006, 2009 |
PISA-OECD |
PISA: sciences performance |
2000, 2003, 2006, 2009 |
PISA-OECD |
Living Conditions
|
Nutrition
|
% population aged 15 years and older overweighed |
2002, 2005, 2010 |
WHO |
Sanitary Facilities
|
% of population with access to adequate sanitation facilities |
2000-2012 |
WHO |
% of urban population with access to adequate sanitation facilities |
2000-2012 |
WHO |
% of rural population with access to adequate sanitation facilities |
2000-2012 |
WHO |
Water
|
% of population with access to adequate water supply |
2000-2012 |
WHO |
% of urban population with access to adequate water supply |
2000-2012 |
WHO |
% of rural population with access to adequate water supply |
2000-2012 |
WHO |
Violence and Mental Health
|
Death rate for homicide |
2000-2011 |
Eurostat – PAHO |
Death rate for suicide |
2000-2010 |
WHO |
Conditions
|
Productive Complex
|
Development and Innovation
|
Gross domestic expenditure on research and development (R&D)in health (millions of dollars – PPP) |
2005-2011 |
OECD |
Health expenditure on R&D as percentage of gross domestic expenditure on R&D |
2005-2011 |
OECD |
Private gross expenditure on R&D in health |
2005-2011 |
OECD |
Public gross expenditure on R&D in health |
2005-2011 |
OECD |
Total number of technological medical patents per applicant country |
2000-2012 |
WIPO |
Total number of pharmaceutical patents per applicant country |
2000-2012 |
WIPO |
Trade Balance
|
Trade balance in pharmaceutical products in millions of dollars |
2008-2012 |
WTO |
Financing
|
Sectorial Expenditure
|
Health expenditure as percentage of gross domestic product (GDP %) |
2000-2012 |
WHO |
Public health expenditure as percentage of total public expenditure |
2000-2012 |
WHO |
Public/Private Composition
|
Private health expenditure as percentage of total health expenditure |
2000-2012 |
WHO |
Out of pocket expenditure as percentage of private health expenditure |
2000-2012 |
WHO |
Private insurance expenditure as percentage of private health expenditure |
2000-2012 |
WHO |
Public health expenditure as percentage of total total health expenditure |
2000-2012 |
WHO |
Performance
|
Effectiveness
|
Primare Care Avoidable Mortality
|
Infant mortality rate |
2000-2012 |
Millenium Indicators |
Under-five mortality rate |
2000-2012 |
Millenium Indicators |
Maternal mortality rate |
2000, 2005 and 2010 |
Millenium Indicators |
Proportional mortality for acute diarrheal diseases in under-five |
2000-2010 |
World Health Organization |
Proportional mortality for acute respiratory diseases in under-five |
2000-2010 |
World Health Organization |
Mortality rate for ischemic heart diseases |
2000-2010 |
Eurostat - PAHO |
Mortality rate for cerebrovascular diseases |
2000-2010 |
Eurostat - PAHO |
Mortality rate for diabetes mellitus |
2000-2010 |
Eurostat - PAHO |
Neonatal mortality rate |
2000-2011 |
Eurostat - PAHO |
Post-neonatal mortality rate |
2000-2011 |
Eurostat - PAHO |
Avoidable Morbidity
|
% of children with low birth weight |
2000-2011 |
PAHO – OECD |
AIDS incidence rate in population aged 15 to 49 years old |
2000-2012 |
Eurostat - PAHO |
Follow-up rate for TB cases treatment |
2007-2011 |
WHO |
Programs Markers
|
% success in Directly Observed Treatment of TB cases with positive sputum baciloscopy . |
2000-2011 |
WHO |